Aarti Drugs Profit & Loss Annual

Trade
BSE: 524348 | NSE: AARTIDRUGS | ISIN: INE767A01016 | Sector: Biotechnology & Drugs
497.50 +2.60 (0.53%)Updated : 23 May 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 2,528.582,716.052,488.652,154.78
Total Revenue 2,528.582,716.052,488.652,154.78
Costof Revenue Total 1,677.722,201.431,967.421,539.31
Gross Profit 850.86514.62521.23615.47
Selling/ General/ Admin Expenses Total 102.34191.38177.01165.73
Depreciation/ Amortization 51.4550.3250.0549.88
Other Operating Expenses Total 432.069.147.264.70
Total Operating Expense 2,263.572,456.932,206.101,767.33
Operating Income 265.01259.13282.55387.45
Interest Inc( Exp) Net- Non- Op Total -335.20-315.36-171.49-176.61
Other Net 4.04-3.414.56-4.04
Net Income Before Taxes 235.53224.18269.96369.01
Provisionfor Income Taxes 63.9357.8264.9688.62
Net Income After Taxes 171.60166.36205.00280.40
Minority Interest -0.17-0.050.040.01
Net Income Before Extra Items 171.43166.31205.04280.41
Net Income 171.43166.31205.04280.41
Total Adjustmentsto Net Income -0.08---
Income Availableto Com Excl Extra Ord 171.42166.31205.04280.41
Income Availableto Com Incl Extra Ord 171.42166.31205.04280.41
Diluted Net Income 171.42166.31205.04280.41
Diluted Weighted Average Shares 9.249.269.269.32
Diluted EPS Excluding Extra Ord Items 18.5617.9622.1430.09
Diluted Normalized EPS 18.5617.9622.1430.07
Research Development -46.5543.5846.64
DPS- Common Stock Primary Issue -1.001.002.50
Unusual Expense( Income) --0.003.04
Gain( Loss)on Saleof Assets --0.0032.67
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,500.00+39.85(1.15%)
2,905.25+19.05(0.66%)
1,135.05+7.35(0.65%)
HomeMarketsPremiumFor youGet App